Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Obesity

New crackdown on ads for ‘less healthy food’ to come into full effect

The ban applies to products that fall within 13 categories considered to play the most significant role in childhood obesity

The Independent UK

The WHO learned to love ‘anti-obesity’ jabs in 2025. I don’t fully agree, but I get it

While GLP-1 drugs promise an easy fix, our bodies still need what they have always needed: healthy food and regular exercise, says chair of global public health at the University of Edinburgh, Prof Devi Sridhar

The Guardian - UK

This Small But Mighty Stock Could Surprise Investors in 2026

This under-the-radar biotech stock is setting up for a big 2026.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock?

As Novo Nordisk’s FDA-approved Wegovy pill sets up a high-stakes comeback, should NVO be back on investors’ radar now?

Barchart

Sleds over screens: Why it’s time to limit your children’s screen time this Christmas

Heavy use of phones, tablets and gaming consoles has been linked to anxiety, depression, poor attention and even obesity.

Euronews

US approves pill version of blockbuster weight-loss drug Wegovy

Availability of oral pills to treat obesity could expand the booming market for obesity treatments by broadening access and reducing costs, experts said.

Euronews

FDA approves Wegovy weight-loss pill in first green-lit alternative to injectable GLP-1 drugs

U.S. regulators have approved a pill version of the weight-loss drug Wegovy, a boon for drugmaker Novo Nordisk

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

India’s doctors sound alarm over boom in availability of weight loss jabs

Country is facing epidemic of diabetes and obesity, but experts say widespread and unregulated use of weight loss drugs could put patients at risk

The Guardian - UK

Pfizer Adds to Its Big Bet on Weight Loss Drugs

A month after acquiring obesity biotech Metsera, Pfizer's expanding in the weight loss drug market after signing a licensing agreement for a weight loss pill.

MarketBeat

A better Ozempic? Eli Lilly’s new obesity drug cut weight by 23%, study finds

In an added benefit, more than one in eight people taking the highest dose of Retratrutide were completely free of arthritic knee pain after 68 weeks

The Independent UK

Eli Lilly CEO David Ricks Unveils $6B Alabama Plant to Produce New Obesity Pill

Eli Lilly CEO David Ricks has announced a new $6 billion manufacturing plant in Alabama dedicated to producing the company's next-generation obesity pill. The move signals Lilly's aggressive expansion as global demand for weight-loss drugs soars.

International Business Times UK

“The Mounjaro Effect”: 40 Mounjaro Users Share Their Weight Loss Journeys

We never know what demons other people are fighting, even if we think we see their problems from the outside. Those who struggle with obesity often have trouble with their self-esteem, body image, anxiety, and depression. Nowadays, weight loss medications like Ozempic and Mounjaro might make their weight loss journeys…

Bored Panda

Weight-loss jabs could have hidden benefit for breast cancer patients

Researchers found a link between the hormone estrone and breast cancer deaths in postmenopausal women

The Independent UK

Wave Life Sciences One-Shot Obesity Drug Slashes Dangerous Visceral Fat

Wave Life Sciences Ltd. (NASDAQ:WVE) on Monday shared interim data from the lowest therapeutic cohort of the ongoing first-in-human INLIGHT trial evaluating WVE-007, an investigational INHBE GalNAc-siRNA using Wave’s proprietary SpiNA design, for obesity.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

The generation ‘at risk of being left behind’ amid mental health and obesity crisis

They are ‘struggling’ to access support as funding hasn’t kept up with demand

International Business Times UK

Ozempic on Cats? Updates on Biopharmaceutical Company Launches Pilot Study of GLP-1 Drug in Obese Cats

An Ozempic-like drug implant might be available for your pets soon. Okava Pharma's GLP-1 implant pilot for obese cats (MEOW-1) aims to combat feline obesity, with due results in 2026.

Benzinga

What's Up With The Jump In Viking Therapeutics Stock?

Viking Therapeutics Inc (NASDAQ:VKTX) shares are trading higher on Thursday. The clinical-stage biopharmaceutical company seems to be benefitting from wider excitement in the obesity treatment area, as well as recent positive momentum after major clinical trial developments.

Evening Standard

Weight loss drugs for pets: Everything you need to know

Okava Pharmaceuticals, a biopharmaceutical company, has launched a pilot study of a GLP-1 drug for cats with obesity

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Scientists find new link between obesity risk and the quality of your marriage

The love hormone, oxytocin, may be able to influence our relationship with food, researchers say

The Guardian - UK

Parents and young people: share your concerns about ultra-processed foods (UPFs)

We’re particularly interested in hearing from parents in low- and middle-income countries where the rise in childhood obesity is steepest

The Independent UK

Weight loss jabs can cut sick days in half, new research finds

Weight loss jabs could keep people in work, according to a study of 700 NHS patients

The Independent UK

The common pre-teen habit that could be fuelling obesity

A study of more than 10,000 12-year-olds found the earlier children acquired smartphones, the greater the risk of obesity, poor sleep, and depression

Euronews

Obesity may speed the onset of Alzheimer’s, scientists say

A small study indicates regular blood tests could be a useful addition to brain scans that track the progression of Alzheimer’s disease.

International Business Times UK

WHO Releases Global Guidelines on Using Weight Loss Jabs In Treating Obesity, Warns About Supply Shortage

The World Health Organisation says GLP‑1 weight‑loss jabs, originally for diabetes, can also treat obesity.

The Independent UK

Obesity speeds up the development of Alzheimer’s disease, study reveals

Obesity is associated with an increase in dementia risk and researchers can now see that it speeds up the development of Alzheimer’s in particular

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the University of Edinburgh

252 stories

WAVE

224 stories

the World Health Organisation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.